2.0
Jun 4, 2016
Former employee, more than 5 years
Darmstadt
Recommend
CEO approval
Business outlook
Pros
family-owned, medium size, long tradition, innovative in several businesses, consensus culture, constant sales growth, willingness to become more vibrant and international
Cons
generally slow decision-making processes and inconsistent implementation of strategy. in pharma not clear whether they want to be generic or innovative company, poor pipeline, very bureaucratic processes linked to the commitment to keep all staff in Germany in lifelong positions; pharma R&D has undergone drastic changes in a positive sense with a lot of multinational new staff even in Germany; Corporate support functions (IT) lagging behind